Overview of pharmacoeconomic modelling methods
In the current climate of burgeoning health care costs, pharmacoeconomics is becoming increasingly important, but knowledge about pharmacoeconomic methods is limited among most clinicians. This review provides an introduction to, and overview of, common methods used in pharmacoeconomic modelling: de...
| Main Authors: | Ademi, Z., Kim, H., Zomer, E., Reid, Christopher, Hollingsworth, B., Liew, D. |
|---|---|
| Format: | Journal Article |
| Published: |
2013
|
| Online Access: | http://hdl.handle.net/20.500.11937/25974 |
Similar Items
Pharmacoeconomic Model Of Dengue Vaccine In Malaysia
by: Tay, Chai Jian
Published: (2018)
by: Tay, Chai Jian
Published: (2018)
Pharmacoeconomics of obesity in China: a scoping review
by: Chen, Zhuo, et al.
Published: (2021)
by: Chen, Zhuo, et al.
Published: (2021)
Outcomes and excess costs among patients with cardiovascular disease
by: Ademi, Z., et al.
Published: (2013)
by: Ademi, Z., et al.
Published: (2013)
Pharmacoeconomic analysis of uncomplicated hypertension in ambulatory care clinic.
by: Qais, Mohammad Ahmad Al-Efan
Published: (2011)
by: Qais, Mohammad Ahmad Al-Efan
Published: (2011)
Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data
by: Ademi, Z., et al.
Published: (2014)
by: Ademi, Z., et al.
Published: (2014)
Is It Cost-Effective To Increase Aspirin Use in Outpatient Settings for Primary or Secondary Prevention? Simulation Data from the REACH Registry Australian Cohort
by: Ademi, Z., et al.
Published: (2013)
by: Ademi, Z., et al.
Published: (2013)
Predicting the impact of polypill use in a metabolic syndrome population: An effectiveness and cost-effectiveness analysis
by: Zomer, E., et al.
Published: (2013)
by: Zomer, E., et al.
Published: (2013)
Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms
by: Zomer, E., et al.
Published: (2014)
by: Zomer, E., et al.
Published: (2014)
Induction of a pharmacoeconomics course in pharmacy curriculum: preliminary findings from the final year cohort
by: Alshami, Abdulkareem Mohammed, et al.
Published: (2015)
by: Alshami, Abdulkareem Mohammed, et al.
Published: (2015)
Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective
by: Zomer, E., et al.
Published: (2018)
by: Zomer, E., et al.
Published: (2018)
Cost-Effectiveness of Optimizing Use of Statins in Australia: Using Outpatient Data From the REACH Registry
by: Ademi, Z., et al.
Published: (2011)
by: Ademi, Z., et al.
Published: (2011)
Economic implications of obesity among people with atherothrombotic disease
by: Ademi, Z., et al.
Published: (2010)
by: Ademi, Z., et al.
Published: (2010)
The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: Best case scenario analysis using a Markov model
by: Zomer, E., et al.
Published: (2012)
by: Zomer, E., et al.
Published: (2012)
Cost-effectiveness of renal denervation therapy for treatment-resistant hypertension: A best case scenario
by: Chowdhury, E., et al.
Published: (2018)
by: Chowdhury, E., et al.
Published: (2018)
More or less physical activity and the effect on cardiovascular mortality in a high-risk population
by: Zomer, E., et al.
Published: (2011)
by: Zomer, E., et al.
Published: (2011)
Validation of two Framingham cardiovascular risk prediction algorithms in an Australian population: The 'old' versus the 'new' Framingham equation
by: Zomer, E., et al.
Published: (2011)
by: Zomer, E., et al.
Published: (2011)
Statins for people at low risk of cardiovascular disease: Authors' reply
by: Zomer, E., et al.
Published: (2012)
by: Zomer, E., et al.
Published: (2012)
An overview of particle methods for random finite set models
by: Ristic, B., et al.
Published: (2016)
by: Ristic, B., et al.
Published: (2016)
COST-UTILITY ANALYSIS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR-BASED TREATMENT COMPARED TO THIAZIDE DIURETIC-BASED TREATMENT IN AN ELDERLY HYPERTENSIVE POPULATION CONSIDERING MAJOR COMORBIDITIES AT THE COMMUNITY LEVEL
by: Chowdhury, E., et al.
Published: (2014)
by: Chowdhury, E., et al.
Published: (2014)
Can oral vitamin D prevent the cardiovascular diseases among migrants in Australia? Provider perspective using Markov modelling
by: Ruwanpathirana, T., et al.
Published: (2015)
by: Ruwanpathirana, T., et al.
Published: (2015)
The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-Year follow-up data from the australian REACH registry
by: Ademi, Z., et al.
Published: (2013)
by: Ademi, Z., et al.
Published: (2013)
An overview on methods for the production of carbon nanotubes
by: Mujawar, Mubarak, et al.
Published: (2014)
by: Mujawar, Mubarak, et al.
Published: (2014)
Cost-effectiveness of angiotensin-converting enzyme inhibitor-based compared to thiazide diuretic-based treatment in an elderly hypertensive population considering diabetes as a major comorbidity
by: Chowdhury, E., et al.
Published: (2015)
by: Chowdhury, E., et al.
Published: (2015)
Cost–Utility of Angiotensin-Converting Enzyme Inhibitor-Based Treatment Compared With Thiazide Diuretic-Based Treatment for Hypertension in Elderly Australians Considering Diabetes as Comorbidity
by: Chowdhury, E., et al.
Published: (2015)
by: Chowdhury, E., et al.
Published: (2015)
Cost-utility of angiotensin-converting enzyme inhibitor compared to thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity
by: Chowdhury, E., et al.
Published: (2015)
by: Chowdhury, E., et al.
Published: (2015)
Modeling of passive piles - an overview
by: Kok, Sien Ti, et al.
Published: (2009)
by: Kok, Sien Ti, et al.
Published: (2009)
DEVELOPMENT OF A CARDIOVASCULAR MORTALITY RISK PREDICTION MODEL FOR PARTICIPANTS IN THE OHASAMA STUDY
by: Huq, M., et al.
Published: (2014)
by: Huq, M., et al.
Published: (2014)
An overview of outlier detection methods
by: Md. Sap, Mohd. Noor, et al.
Published: (2008)
by: Md. Sap, Mohd. Noor, et al.
Published: (2008)
Modelling and Simulation: An Overview
by: McAleer, M., et al.
Published: (2013)
by: McAleer, M., et al.
Published: (2013)
Protein and peptide biopharmaceuticals: An overview
by: Agyei, D., et al.
Published: (2017)
by: Agyei, D., et al.
Published: (2017)
A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era
by: Ariyaratne, T., et al.
Published: (2016)
by: Ariyaratne, T., et al.
Published: (2016)
PROLONGED EFFECTIVENESS OF CORONARY ARTERY BYPASS SURGERY VERSUS DRUG-ELUTING STENTS IN DIABETICS WITH MULTI-VESSEL DISEASE: AN UPDATED META-ANALYSIS
by: Ariyaratne, T., et al.
Published: (2012)
by: Ariyaratne, T., et al.
Published: (2012)
Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease: An updated systematic review and meta-analysis
by: Ariyaratne, T., et al.
Published: (2014)
by: Ariyaratne, T., et al.
Published: (2014)
Risk management overview of tunnels using numerical modeling
by: Ghiasi, Vahed, et al.
Published: (2011)
by: Ghiasi, Vahed, et al.
Published: (2011)
Potential Data Collections Methods for System Dynamics Modelling: A Brief Overview
by: Aisyah, Ibrahim, et al.
Published: (2021)
by: Aisyah, Ibrahim, et al.
Published: (2021)
Heterogeneity in ordered choice models: A review with applications to self-assessed health
by: Greene, W., et al.
Published: (2012)
by: Greene, W., et al.
Published: (2012)
IR models and approaches: an overview
by: Othman, Roslina
Published: (2011)
by: Othman, Roslina
Published: (2011)
Nineteenth-century Shakespeares: nationalism and moralism
by: Hollingsworth, Mark
Published: (2007)
by: Hollingsworth, Mark
Published: (2007)
An overview of the current analytical methods for halal testing
by: Jaswir, Irwandi, et al.
Published: (2016)
by: Jaswir, Irwandi, et al.
Published: (2016)
Methods to determine the mine gas explosibility - An overview
by: Cheng, Jianwei, et al.
Published: (2012)
by: Cheng, Jianwei, et al.
Published: (2012)
Similar Items
-
Pharmacoeconomic Model Of Dengue Vaccine In Malaysia
by: Tay, Chai Jian
Published: (2018) -
Pharmacoeconomics of obesity in China: a scoping review
by: Chen, Zhuo, et al.
Published: (2021) -
Outcomes and excess costs among patients with cardiovascular disease
by: Ademi, Z., et al.
Published: (2013) -
Pharmacoeconomic analysis of uncomplicated hypertension in ambulatory care clinic.
by: Qais, Mohammad Ahmad Al-Efan
Published: (2011) -
Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data
by: Ademi, Z., et al.
Published: (2014)